Biogen (NASDAQ: BIIB) free cash flow
Biogen reported free cash flow of $2,051m for fiscal 2025: $2,205m of operating cash flow minus $153.8m of capital expenditure. That is 24.7% less than in fiscal 2024. It equals 20.7% of revenue.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Free cash flow by fiscal year
| Fiscal year | Free cash flow | Change | Operating cash flow | Capital expenditure | Share of revenue |
|---|---|---|---|---|---|
| 2025 | $2,051m | −24.7% | $2,205m | $153.8m | 20.7% |
| 2024 | $2,722m | +114.3% | $2,876m | $153.7m | 28.1% |
| 2023 | $1,270m | +11.0% | $1,547m | $277.0m | 12.9% |
| 2022 | $1,144m | −66.2% | $1,384m | $240.3m | 11.2% |
| 2021 | $3,382m | −11.1% | $3,640m | $258.1m | 30.8% |
| 2020 | $3,805m | −42.0% | $4,230m | $424.8m | 28.3% |
| 2019 | $6,564m | +21.2% | $7,079m | $514.5m | 45.7% |
| 2018 | $5,417m | +47.1% | $6,188m | $770.6m | 40.3% |
| 2017 | $3,684m | −7.2% | $4,551m | $867.4m | 30.0% |
| 2016 | $3,971m | — | $4,587m | $616.1m | 34.7% |
Free cash flow is operating cash flow minus capital expenditure, both from the cash flow statement in the same filing. The change compares each fiscal year with the one before and is not calculated when the previous year was negative. Figures are in millions of US dollars, except per-share amounts.
Questions about the free cash flow of Biogen
- How much free cash flow did Biogen generate in fiscal 2025?
- Biogen reported free cash flow of $2,051m for fiscal 2025. In fiscal 2024 it was free cash flow of $2,722m.
- How is the free cash flow of Biogen calculated?
- It is operating cash flow minus capital expenditure, both from the cash flow statement in its accounts: in fiscal 2025, $2,205m minus $153.8m.
- What share of its revenue does Biogen turn into free cash flow?
- In fiscal 2025, 20.7% of its revenue.
- What was the best year for free cash flow at Biogen?
- Of its last 10 fiscal years, fiscal 2019, with $6,564m.
- Where do the figures for Biogen come from?
- From the annual report (Form 10-K) that Biogen files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Biogen files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Biogen: the Biogen page · annual accounts · revenue · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.